{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34475433", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "02"}], "Language": ["eng"], "ELocationID": ["17531", "10.1038/s41598-021-96457-7"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "02"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation.", "Pagination": {"StartPage": "17531", "MedlinePgn": "17531"}, "Abstract": {"AbstractText": ["Organ transplant is often the treatment of choice as it extends and improves patient life. Immunosuppressive treatment, which prevents acute rejection of the organ, is used in transplant patients to prevent the loss of transplant. The aim of the study was to determine the impact of the CTLA4 (+49A>G, rs231775) and the TGF-\u03b21 (-800G>A, rs1800468) polymorphisms on the therapeutic effect of immunosuppressive drugs (cyclosporine-CsA, tacrolimus-TAC) and the risk of acute rejection in renal transplant patients. The analysis of the CTLA4 +49A>G and the TGF-\u03b21 -800G>A polymorphisms was carried out in 392 patients after kidney transplant using real-time PCR. The CTLA4\u2009+49A>G polymorphism did not affect CsA or TAC dose, ratio of drug concentration to dose (C/D), and blood concentrations. As for the TGF-\u03b21 -800G>A polymorphism, patients with the GA genotype required lower TAC doses compared to the GG genotype (TAC 12\u00a0h: 3.63\u00a0mg vs 5.3\u00a0mg, TAC 24\u00a0h: 2.38\u00a0mg vs 3.29\u00a0mg). Comparing the C/D ratio in both groups (TAC 12\u00a0h and TAC 24\u00a0h), higher C/D ratio was observed in patients with the GA genotype. These results indicate that patients with the A allele require slightly lower doses of TAC. The results suggest that the TGF-\u03b21 -800 G>A polymorphism may influence the TAC dose, while the\u2009+49A>G polymorphism of the CTLA4 gene does not correlate with the dose of CsA or TAC. The analysis of the biochemical parameters of the renal profile showed no impact of the CTLA4 and the TGF-\u03b21 polymorphisms on the risk of organ rejection."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630, Poznan, Poland. aniabogacz23@o2.pl."}, {"Identifier": [], "Affiliation": "Department of Histocompatibility with Laboratory of Genetic Diagnostics, Regional Blood Center, Marceli\u0144ska 44, 60-354, Poznan, Poland. aniabogacz23@o2.pl."}], "LastName": "Bogacz", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630, Poznan, Poland."}], "LastName": "Wolek", "ForeName": "Marlena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery and Transplantation, Pomeranian Medical University, Powsta\u0144c\u00f3w Wlkp. 72, 70-111, Szczecin, Poland."}], "LastName": "Sie\u0144ko", "ForeName": "Jerzy", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630, Poznan, Poland."}, {"Identifier": [], "Affiliation": "Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University, \u017bo\u0142nierska 48, 71-230, Szczecin, Poland."}], "LastName": "Czerny", "ForeName": "Bogus\u0142aw", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Pathology, Pomeranian Medical University, Powsta\u0144c\u00f3w Wlkp. 72, 70-111, Szczecin, Poland."}], "LastName": "Machali\u0144ski", "ForeName": "Bogus\u0142aw", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinic of Operational Gynecology, Poznan University of Medical Sciences, Polna 33, 60-535, Poznan, Poland."}], "LastName": "Olbromski", "ForeName": "Piotr", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery and Transplantation, Pomeranian Medical University, Powsta\u0144c\u00f3w Wlkp. 72, 70-111, Szczecin, Poland."}, {"Identifier": [], "Affiliation": "Department of General Pathology, Pomeranian Medical University, Powsta\u0144c\u00f3w Wlkp. 72, 70-111, Szczecin, Poland."}], "LastName": "Kotowski", "ForeName": "Maciej", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "CTLA-4 Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "CTLA4 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunosuppressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "TGFB1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta1"}, {"RegistryNumber": "83HN0GTJ6D", "NameOfSubstance": "Cyclosporine"}, {"RegistryNumber": "EC 3.1.3.16", "NameOfSubstance": "Calcineurin"}, {"RegistryNumber": "WM0HAQ4WNM", "NameOfSubstance": "Tacrolimus"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["genetics"], "DescriptorName": "CTLA-4 Antigen"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Calcineurin"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Cyclosporine"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug therapy", "etiology", "metabolism", "pathology"], "DescriptorName": "Graft Rejection"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Immunosuppressive Agents"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Kidney Transplantation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Polymorphism, Single Nucleotide"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Tacrolimus"}, {"QualifierName": ["genetics"], "DescriptorName": "Transforming Growth Factor beta1"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Young Adult"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chang CH, et al. Increased chronic kidney disease development and progression in diabetic patients after appendectomy: A population-based cohort study. PeerJ. 2018;6:e5019. doi: 10.7717/peerj.5019.", "ArticleIdList": ["10.7717/peerj.5019", "PMC6004103", "29915707"]}, {"Citation": "Ograczyk E, Kowalewicz-Kulbat M, Wawrocki S, Fol M. Immunosuppression\u2014tough ally in torrid time. Adv. Clin. Exp. Med. 2015;69:1299\u20131312.", "ArticleIdList": ["26671921"]}, {"Citation": "Feldman G, et al. Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function. J. Am. Soc. Nephrol. 2007;18(6):1662\u20131671. doi: 10.1681/ASN.2006050527.", "ArticleIdList": ["10.1681/ASN.2006050527", "17460148"]}, {"Citation": "D\u0142ugosz A, \u015arednicka D, Boraty\u0144ski J. The influence of tacrolimus on oxidative stress and free-radical processes. Adv. Clin. Exp. Med. 2007;61:466\u2013471.", "ArticleIdList": ["17786133"]}, {"Citation": "Kocierz M, Kujawa-Szewieczek A, Kolonko A, Chudek J. The influence of selected cytokine gene polymorphisms on the occurrence of acute and chronic rejection and on kidney graft survival. Adv. Clin. Exp. Med. 2009;63:613\u2013626.", "ArticleIdList": ["20097948"]}, {"Citation": "Grinyo J, Vanrenterghem Y, Nashan B. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl. Int. 2008;9:879\u2013891. doi: 10.1111/j.1432-2277.2008.00679.x.", "ArticleIdList": ["10.1111/j.1432-2277.2008.00679.x", "18444945"]}, {"Citation": "Loeffler I, Wolf G. Transforming growth factor-\u03b2 and the progression of renal disease. Nephrol. Dial. Transplant. 2014;29(1):i37\u2013i45. doi: 10.1093/ndt/gft267.", "ArticleIdList": ["10.1093/ndt/gft267", "24030832"]}, {"Citation": "Djamali A, Samaniego M. Fibrogenesis in kidney transplantation: Potential targets for prevention and therapy. Transplantation. 2009;88(10):1149\u20131156. doi: 10.1097/TP.0b013e3181bcccea.", "ArticleIdList": ["10.1097/TP.0b013e3181bcccea", "PMC2784657", "19935366"]}, {"Citation": "Doma\u0144ski L, et al. The impact of rs231775 (+49AG) CTLA4 gene polymorphism on transplanted kidney function. Ann. Transplant. 2012;17(3):29\u201335. doi: 10.12659/AOT.883455.", "ArticleIdList": ["10.12659/AOT.883455", "23018253"]}, {"Citation": "Mewes C, B\u00fcttner B, Hinz J. The CTLA-4 rs231775 GG genotype is associated with favorable 90-day survival in Caucasian patients with sepsis. Sci. Rep. 2018;8(1):15140. doi: 10.1038/s41598-018-33246-9.", "ArticleIdList": ["10.1038/s41598-018-33246-9", "PMC6181961", "30310101"]}, {"Citation": "Ohl K, Eberhardt Ch, Spink C. CTLA4 polymorphisms in minimal change nephrotic syndrome in children: A case\u2013control study. Am. J. Kidney Dis. 2014;63:6. doi: 10.1053/j.ajkd.2014.01.427.", "ArticleIdList": ["10.1053/j.ajkd.2014.01.427", "24656396"]}, {"Citation": "Eikmans M, et al. Non-invasive biomarkers of acute rejection in kidney transplantation: Novel targets and strategies. Front. Med. 2019;5:358. doi: 10.3389/fmed.2018.00358.", "ArticleIdList": ["10.3389/fmed.2018.00358", "PMC6331461", "30671435"]}, {"Citation": "Kotowski MJ, Bogacz A, Bartkowiak-Wieczorek J, Tejchman K, Dziewanowski K, et al. Effect of multidrug-resistant 1 (MDR1) and CYP3A4*1B polymorphisms on cyclosporine-based immunosuppressive therapy in renal transplant patients. Ann. Transplant. 2019;24:108\u2013114. doi: 10.12659/AOT.914683.", "ArticleIdList": ["10.12659/AOT.914683", "PMC6400024", "30799432"]}, {"Citation": "Duan Z, Zhang Y, Pan F. Association between CTLA4 gene polymorphisms and acute rejection of kidney transplantation: A meta-analysis. J. Nephrol. 2012;25(6):996\u20131002. doi: 10.5301/jn.5000082.", "ArticleIdList": ["10.5301/jn.5000082", "22307437"]}, {"Citation": "Zhu C, Huang Q, Liu C. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients. Mol. Biol. Rep. 2012;39(9):8701\u20138708. doi: 10.1007/s11033-012-1727-4.", "ArticleIdList": ["10.1007/s11033-012-1727-4", "22711308"]}, {"Citation": "Kim HJ, Jeong KH, Lee SH. Polymorphisms of the CTLA4 gene and kidney transplant rejection in Korean patients. Transpl. Immunol. 2010;24(1):40\u201344. doi: 10.1016/j.trim.2010.10.001.", "ArticleIdList": ["10.1016/j.trim.2010.10.001", "20940051"]}, {"Citation": "Gao JW, Zhou ZH, Guo SC. A deeper understanding of the association between CTLA4 +49A/G and acute rejection in renal transplantation: An updated meta-analysis. Renal. Fail. 2015;37(1):165\u2013174. doi: 10.3109/0886022X.2014.970470.", "ArticleIdList": ["10.3109/0886022X.2014.970470", "25299395"]}, {"Citation": "Kusztal M, et al. The influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients. Transpl. Immunol. 2010;23(3):121\u2013124. doi: 10.1016/j.trim.2010.05.002.", "ArticleIdList": ["10.1016/j.trim.2010.05.002", "20470888"]}, {"Citation": "Guo Y, Gao J, Gao S. Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients. Oncotarget. 2016;7(17):23088\u201323095. doi: 10.18632/oncotarget.8714.", "ArticleIdList": ["10.18632/oncotarget.8714", "PMC5029612", "27081086"]}, {"Citation": "Dmitrienko S, Hoar DI, Balshaw R, Keown P. Immune response gene polymorphisms in renal transplant recipients. Transplantation. 2005;80(12):1773\u20131782. doi: 10.1097/01.tp.0000184624.54005.9f.", "ArticleIdList": ["10.1097/01.tp.0000184624.54005.9f", "16378074"]}, {"Citation": "Nikolova PN, Ivanova MI, Mihailova SM. Cytokine gene polymorphism in kidney transplantation\u2014impact of TGF-\u03b21, TNF-\u03b1 and IL-6 on graft outcome. Transpl. Immunol. 2008;18(4):344\u2013348. doi: 10.1016/j.trim.2007.10.003.", "ArticleIdList": ["10.1016/j.trim.2007.10.003", "18158121"]}, {"Citation": "Inigo P, et al. Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients. Nefrologia. 2003;23(4):312\u2013320.", "ArticleIdList": ["14558330"]}, {"Citation": "Niknam A, Karimi MH, Yaghobi R. The association between viral infections and co-stimulatory gene polymorphisms in kidney transplant outcomes. Jundishapur J. Microbiol. 2016;9(8):31338. doi: 10.5812/jjm.31338.", "ArticleIdList": ["10.5812/jjm.31338", "PMC5076488", "27800130"]}, {"Citation": "Ozdemir BH, Ozdemir FN, Demirhan B, Haberal M. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity. Transplantation. 2005;80(12):1681\u20131685. doi: 10.1097/01.tp.0000185303.92981.d6.", "ArticleIdList": ["10.1097/01.tp.0000185303.92981.d6", "16378061"]}, {"Citation": "Harris S, Coupes BM, Roberts SA. TGF-beta1 in chronic allograft nephropathy following renal transplantation. J. Nephrol. 2007;20(2):177\u2013185.", "ArticleIdList": ["17514622"]}, {"Citation": "Del Prete D, Ceol M, Anglani F, Vianello D. Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies. Exp. Mol. Pathol. 2009;87(2):141\u2013145. doi: 10.1016/j.yexmp.2009.07.004.", "ArticleIdList": ["10.1016/j.yexmp.2009.07.004", "19616542"]}, {"Citation": "Morris-Stiff G. TGF beta-1 and the development of chronic graft nephropathy: Relative roles of gene, mRNA and protein. Ann. R. Coll. Surg. Eng. 2005;87(5):326\u2013330. doi: 10.1308/003588405X60533.", "ArticleIdList": ["10.1308/003588405X60533", "PMC1963971", "16176689"]}, {"Citation": "Tinckam K, Rush D, Hutchinson I. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and sixmonth renal allograft pathology. Transplantation. 2005;79:836\u2013841. doi: 10.1097/01.TP.0000155187.81806.DF.", "ArticleIdList": ["10.1097/01.TP.0000155187.81806.DF", "15818327"]}, {"Citation": "Lacha J, Hribova P, Kotsch K. Effect of cytokines and chemokines (TGF-b, TNF-a, IL-6, IL-10, MCP-1, RANTES) gene polymorphisms in kidney recipients on posttransplantation outcome: Influence of donor-recipient match. Transplant. Proc. 2005;37:764\u2013766. doi: 10.1016/j.transproceed.2004.12.224.", "ArticleIdList": ["10.1016/j.transproceed.2004.12.224", "15848524"]}, {"Citation": "Waiser J, Dell K, Bohler T. Cyclosporine A up-regulates the expression of TGF-b1 and its receptors type I and type II in rat mesangial cells. Nephrol. Dial. Transplant. 2002;17:1568\u20131577. doi: 10.1093/ndt/17.9.1568.", "ArticleIdList": ["10.1093/ndt/17.9.1568", "12198207"]}, {"Citation": "Andr\u00e9 N, Roquelaure B, Conrath J. Molecular effects of cyclosporine and oncogenesis: A new model. Med. Hypotheses. 2004;63(4):647\u2013562. doi: 10.1016/j.mehy.2004.03.030.", "ArticleIdList": ["10.1016/j.mehy.2004.03.030", "15325009"]}, {"Citation": "Akool EL-S, Doller A, Babelova A. Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506. J. Immunol. 2008;181(4):2831\u20132845. doi: 10.4049/jimmunol.181.4.2831.", "ArticleIdList": ["10.4049/jimmunol.181.4.2831", "18684975"]}, {"Citation": "Khanna A, Plummer M, Bromberek C. Expression of TGF-\u03b2 and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int. 2002;62(6):2257\u20132263. doi: 10.1046/j.1523-1755.2002.00668.x.", "ArticleIdList": ["10.1046/j.1523-1755.2002.00668.x", "12427154"]}, {"Citation": "Seyhun Y, Ciftci HS, Kekik C. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-\u03b2, tumour necrosis factor-\u03b1 and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients. Int. J. Immunogenet. 2015;42(3):147\u2013160. doi: 10.1111/iji.12192.", "ArticleIdList": ["10.1111/iji.12192", "25817300"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "5", "Day": "6"}, {"Year": "2021", "Month": "7", "Day": "29"}, {"Year": "2021", "Month": "9", "Day": "3", "Hour": "6", "Minute": "17"}, {"Year": "2021", "Month": "9", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["34475433", "PMC8413317", "10.1038/s41598-021-96457-7", "10.1038/s41598-021-96457-7"]}}], "PubmedBookArticle": []}